Pages that link to "Q40328434"
Jump to navigation
Jump to search
The following pages link to Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response. (Q40328434):
Displaying 50 items.
- Vaccination Strategies for Alzheimer???s Disease (Q22241439) (← links)
- Immunotherapy as treatment for Alzheimer’s disease (Q22241491) (← links)
- Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease (Q24599108) (← links)
- Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease (Q27023953) (← links)
- Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease (Q27349010) (← links)
- Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity (Q30277159) (← links)
- A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model (Q30581976) (← links)
- Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease (Q30835636) (← links)
- Molecules that target beta-amyloid (Q33303421) (← links)
- T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease (Q33593098) (← links)
- Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine (Q33742312) (← links)
- Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds. (Q33935251) (← links)
- Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow (Q33947287) (← links)
- Amyloid-beta immunotherapy for Alzheimer's disease (Q33954737) (← links)
- DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. (Q33957114) (← links)
- Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease (Q34080692) (← links)
- Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP PS1 mice (Q34506405) (← links)
- IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice (Q35147651) (← links)
- Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention (Q35156471) (← links)
- Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice. (Q35792042) (← links)
- Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice (Q35834451) (← links)
- Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1 (Q35842741) (← links)
- Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage (Q35844472) (← links)
- Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy (Q35928266) (← links)
- Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice. (Q36052412) (← links)
- A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease (Q36240389) (← links)
- Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice. (Q36269285) (← links)
- Preventive immunization of aged and juvenile non-human primates to β-amyloid (Q36391157) (← links)
- A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice (Q36482937) (← links)
- Deregulated Cdk5 activity is involved in inducing Alzheimer's disease (Q36494716) (← links)
- Yeast expressed foldable quadrivalent Aβ15 elicited strong immune response against Aβ without Aβ-specific T cell response in wild C57BL/6 mice (Q36552898) (← links)
- 100 years and counting: prospects for defeating Alzheimer's disease (Q36643419) (← links)
- Disease-modifying therapies in Alzheimer's disease: how far have we come? (Q36656437) (← links)
- The PPAR-gamma Agonist 15-Deoxy-Delta-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease (Q36742787) (← links)
- Amyloid-beta aggregation (Q36788949) (← links)
- Small molecule inhibitors of Abeta assembly (Q36911406) (← links)
- Anti-dementia drugs and hippocampal-dependent memory in rodents (Q36925129) (← links)
- Advances in the development of vaccines for Alzheimer's disease (Q36965988) (← links)
- An update of animal models of Alzheimer disease with a reevaluation of plaque depositions (Q36976873) (← links)
- Pharmacotherapy of Alzheimer disease (Q37004359) (← links)
- Novel strategies for Alzheimer's disease treatment (Q37012066) (← links)
- Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? (Q37118083) (← links)
- Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives (Q37267918) (← links)
- Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. (Q37308949) (← links)
- Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies (Q37340312) (← links)
- The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity (Q37345527) (← links)
- BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. (Q37353095) (← links)
- Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy (Q37438261) (← links)
- AD vaccines: conclusions and future directions (Q37438273) (← links)
- Computational study of the inhibitory mechanism of the kinase CDK5 hyperactivity by peptide p5 and derivation of a pharmacophore (Q37503295) (← links)